C

프롬바이오

377220KOSDAQ기타 식품 제조업

51.8 / 100

Reference Date: 2026-07-24

Financial Score12.5 / 40
News Sentiment21.3 / 25
Momentum8.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 14.5% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

PromBIO is a comprehensive health functional food company operating the entire value chain, leveraging its ownership of individually certified functional ingredients and R&D capabilities to establish a strong market position. Focusing on its flagship Boswellia and Mastica product lines, the company is expanding into cosmetics and new areas such as cell culture and stem cell research.

Number of Employees

147people

Average Salary

37.9M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 12.074.0Point
PBR
0.56Industry Average 0.542.5Point

Higher than industry avg (caution)

ROE
-61.68Industry Average 2.720.0Point

Well below industry avg

Debt Ratio
7.75Industry Average 11.915.0Point

Lower than industry avg (good)

Trend 2023~20251.0 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲4.0% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼17.0% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -39.4% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 513Won52-week high 1,96052-week low 513
1-month return1.0Point

1m -14.50% (falling)

Volume trend6.0Point

Volume surge

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0
  • Neutral주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)2026-07-14
  • Neutral임시주주총회결과2026-07-06
  • Neutral[기재정정]임원ㆍ주요주주특정증권등소유상황보고서2026-07-02
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-01